folic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, AM; Alenazy, FO; Alhassan, HH; Davuljigari, CB; Elderdery, AY; Elkhalifa, AME; Mills, J; Shalabi, MG; Tebein, EM | 1 |
| BRAHIN, C; KRIM, M; MEYER, LM; RITZ, N | 1 |
| BARRELET, J | 1 |
| SPAMPINATO, V | 1 |
| KLIMA, R; WENGRAF, G | 1 |
| Bigler, J; Bruemmer, B; Gooley, T; Potter, JD; Radich, JP; Robien, K; Ulrich, CM; Yasui, Y | 1 |
| Bigler, J; Chay, T; Potter, JD; Robien, K; Schubert, MM; Storb, R; Ulrich, CM; Yasui, Y | 1 |
| Martin, P; Potter, JD; Robien, K; Schubert, MM; Storb, R; Ulrich, CM; Yasui, Y | 1 |
| Cho, HC; Cho, HI; Hur, M; Lee, KM; Park, JY; Shin, HY | 1 |
| Gibson, W; Jackman, AL; Kimbell, R; Kobayashi, H; Miyachi, H; Takemura, Y | 1 |
| McLean, GR; Morgan, AC; Quadros, EV; Rothenberg, SP; Schrader, JW; Ziltener, HJ | 1 |
| Kobayashi, H; Ohnuma, T; Takemura, Y | 1 |
| Chen, J; Liu, X; Zhou, Q | 1 |
13 other study(ies) available for folic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients.
Topics: Ferredoxin-NADP Reductase; Folic Acid; Genetic Predisposition to Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methionine | 2022 |
Remission in chronic myelocytic leukemia during folic acid therapy.
Topics: Folic Acid; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid | 1954 |
[Biermer's anemia; folic acid therapy; funicular myelosis].
Topics: Anemia; Anemia, Pernicious; Folic Acid; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myelitis | 1950 |
[Funicular myelosis due to folic acid in Mus musculus albinus; preliminary note].
Topics: Folic Acid; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Myelitis | 1952 |
[Comparative observations on the effect of folic acid and liver extract in the treatment of pernicious anemia and funicular myelosis].
Topics: Anemia; Anemia, Pernicious; Folic Acid; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Liver Extracts; Primary Myelofibrosis; Spine | 1950 |
Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia.
Topics: Adolescent; Adult; Aged; Cohort Studies; Female; Folic Acid; Fusion Proteins, bcr-abl; Genotype; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Proportional Hazards Models; Protein Binding; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Risk; RNA, Messenger; Time Factors | 2004 |
Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation.
Topics: Alleles; Cohort Studies; DNA; Folic Acid; Genotype; Hematopoietic Stem Cell Transplantation; Homozygote; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; RNA, Messenger; Stomatitis; Thymidylate Synthase; Time Factors | 2006 |
Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cohort Studies; Dietary Supplements; Female; Folic Acid; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2006 |
Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Confidence Intervals; Female; Folic Acid; Gene Frequency; Humans; Infant; Korea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Assessment | 2006 |
Cellular pharmacokinetics of ZD1694 in cultured human leukaemia cells sensitive, or made resistant, to this drug.
Topics: Antimetabolites, Antineoplastic; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Folic Acid; Humans; Intracellular Fluid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Polyglutamic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; Tetrahydrofolate Dehydrogenase; Thiophenes; Thymidylate Synthase; Tritium; Tumor Cells, Cultured | 1996 |
Antibodies to transcobalamin II block in vitro proliferation of leukemic cells.
Topics: Antibodies, Monoclonal; Apoptosis; Cell Division; Folic Acid; Growth Inhibitors; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Neoplastic Stem Cells; Transcobalamins; Tumor Cells, Cultured; Vitamin B 12 | 1997 |
Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Carrier Proteins; Drug Resistance, Neoplasm; Folic Acid; Folic Acid Antagonists; Humans; Leucovorin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; Tetrahydrofolate Dehydrogenase; Thiophenes; Tumor Cells, Cultured | 1998 |
[Radioimmunoassay of serum vitamin B12 and folic acid in patients with pernicious hemopathy].
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Diagnosis, Differential; Female; Folic Acid; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Radioimmunoassay; Vitamin B 12 | 1999 |